Diazepam buccal film - MonoSol Rx

Drug Profile

Diazepam buccal film - MonoSol Rx

Alternative Names: Diazepam - MonoSol Rx; Diazepam BSF; Diazepam buccal soluble film

Latest Information Update: 10 Jan 2017

Price : $50

At a glance

  • Originator MonoSol Rx
  • Class Antiepileptic drugs; Anxiolytics; Benzodiazepines; Benzodiazepinones; Hypnosedatives; Muscle relaxants; Small molecules
  • Mechanism of Action GABA receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Seizures
  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No

Highest Development Phases

  • Clinical Phase Unknown Seizures

Most Recent Events

  • 06 Jan 2017 MonoSol Rx completes a dose proportionality study for Seizures (acute repetitive)
  • 01 Jan 2017 MonoSol Rx initiates enrolment in a dose proportionality study for Seizures (acute repetitive) before January 2017
  • 30 Nov 2016 Diazepam buccal film - MonoSol Rx receives Orphan Drug status for Seizures (acute repetitive seizures) in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top